SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl) N-(3-pyridinylmethyl)ethanesulfonamide

被引：48

作者：

Barda, DA ^{[1
]}

Wang, ZQ ^{[1
]}

Britton, TC ^{[1
]}

Henry, SS ^{[1
]}

Jagdmann, GE ^{[1
]}

Coleman, DS ^{[1
]}

Johnson, MP ^{[1
]}

Andis, SL ^{[1
]}

Schoepp, DD ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 12期

关键词：

glutamate; allosteric potentiators; mGlu2; receptor;

D O I：

10.1016/j.bmcl.2004.04.017

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The major excitatory neurotransmitter in the Central Nervous System is L-glutamic acid. As a result much attention has been given to the discovery of selective modulators of both the ionotropic glutamate receptors (iGluRs) and the metabotropic glutamate receptors (mGluRs). In this study we describe a novel class of subtype selective allosteric potentiators of the mGlu2 receptor. An active compound N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide, LY181837, was identified in the course of compound screening. The synthesis of two series of analogs examined the structural requirements of the diaryl region of this compound. This SAR study also resulted in compounds with an increase in potency of over 100-fold where the most potent compound reported has EC50 = 14 nM. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：3099 / 3102

页数：4

共 14 条

[1]

Britton T, 2002, NEUROPHARMACOLOGY, V43, P279

[2] Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives [J].

Gasparini, F ;

Kuhn, R ;

Pin, JP .

CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (01) :43-49

[3]

Johnson K, 2002, NEUROPHARMACOLOGY, V43, P291

[4] Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor:: Synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethyl-amine [J].

Johnson, MP ;

Baez, M ;

Jagdmann, GE ;

Britton, TC ;

Large, TH ;

Callagaro, DO ;

Tizzano, JP ;

Monn, JA ;

Schoepp, DD .

JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (15) :3189-3192

[5] LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors [J].

Kingston, AE ;

Ornstein, PL ;

Wright, RA ;

Johnson, BG ;

Mayne, NG ;

Burnett, JP ;

Belagaje, R ;

Wu, S ;

Schoepp, DD .

NEUROPHARMACOLOGY, 1998, 37 (01) :1-12

[6] Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site [J].

Knoflach, F ;

Mutel, V ;

Kew, JNC ;

Malherbe, P ;

Vieira, E ;

Wichmann, J ;

Kemp, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) :13402-13407

[7] Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge [J].

Lorrain, DS ;

Schaffhauser, H ;

Campbell, UC ;

Baccei, CS ;

Correa, LD ;

Rowe, B ;

Rodriguez, DE ;

Anderson, JJ ;

Varney, MA ;

Pinkerton, AB ;

Vernier, JM ;

Bristow, LJ .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) :1622-1632

[8]

Monn J.A., 1997, ANNU REP MED CHEM, V32, P1

[9] Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors [J].

Monn, JA ;

Valli, MJ ;

Massey, SM ;

Hansen, MM ;

Kress, TJ ;

Wepsiec, JP ;

Harkness, AR ;

Grutsch, JL ;

Wright, RA ;

Johnson, BG ;

Andis, SL ;

Kingston, A ;

Tomlinson, R ;

Lewis, R ;

Griffey, KR ;

Tizzano, JP ;

Schoepp, DD .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) :1027-1040

[10] Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties [J].

Monn, JA ;

Valli, MJ ;

Massey, SM ;

Wright, RA ;

Salhoff, CR ;

Johnson, BG ;

Howe, T ;

Alt, CA ;

Rhodes, GA ;

Robey, RL ;

Griffey, KR ;

Tizzano, JP ;

Kallman, MJ ;

Helton, DR ;

Schoepp, DD .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (04) :528-537

← 1 2 →